162 related articles for article (PubMed ID: 37322603)
1. Curcumin inhibits human cancer cell growth and migration through downregulation of SVCT2.
Jang SY; Kim J; Hong E; Lee K; Na Y; Yeom CH; Park S
Cell Biochem Funct; 2023 Aug; 41(6):696-703. PubMed ID: 37322603
[TBL] [Abstract][Full Text] [Related]
2. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health.
Kocaadam B; Şanlier N
Crit Rev Food Sci Nutr; 2017 Sep; 57(13):2889-2895. PubMed ID: 26528921
[TBL] [Abstract][Full Text] [Related]
3. Role of p53 in transcriptional repression of SVCT2.
Kim EH; Koh DI; Ryu YS; Park SS; Hong SW; Moon JH; Shin JS; Kim MJ; Kim DY; Hong JK; Jeong HR; Yun H; Shin JY; Kim J; Park YS; Kim DM; Jin DH
Mol Biol Rep; 2021 Feb; 48(2):1651-1658. PubMed ID: 33580460
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of SVCT2 impairs in-vitro cell attachment, migration and wound healing in bone marrow stromal cells.
Sangani R; Pandya CD; Bhattacharyya MH; Periyasamy-Thandavan S; Chutkan N; Markand S; Hill WD; Hamrick M; Isales C; Fulzele S
Stem Cell Res; 2014 Mar; 12(2):354-63. PubMed ID: 24365600
[TBL] [Abstract][Full Text] [Related]
5. Sodium-dependent vitamin C transporter SVCT2: expression and function in bone marrow stromal cells and in osteogenesis.
Fulzele S; Chothe P; Sangani R; Chutkan N; Hamrick M; Bhattacharyya M; Prasad PD; Zakhary I; Bowser M; Isales C; Ganapathy V
Stem Cell Res; 2013 Jan; 10(1):36-47. PubMed ID: 23089627
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Curcumin on the Downregulation of MYC, Insulin and IGF-1 Receptors: A possible Mechanism Underlying the Anti-Growth and Anti-Migration in Chemoresistant Colorectal Cancer Cells.
Hosseini SA; Zand H; Cheraghpour M
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987250
[No Abstract] [Full Text] [Related]
7. Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review.
Memarzia A; Khazdair MR; Behrouz S; Gholamnezhad Z; Jafarnezhad M; Saadat S; Boskabady MH
Biofactors; 2021 May; 47(3):311-350. PubMed ID: 33606322
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
Jurenka JS
Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
[TBL] [Abstract][Full Text] [Related]
9. SVCT2/SLC23A2 is a sodium-dependent urate transporter: functional properties and practical application.
Toyoda Y; Miyata H; Shigesawa R; Matsuo H; Suzuki H; Takada T
J Biol Chem; 2023 Aug; 299(8):104976. PubMed ID: 37390985
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of curcumin and its related substances in turmeric: From raw material selection to application strategies.
Hsu KY; Ho CT; Pan MH
J Food Drug Anal; 2023 Jun; 31(2):194-211. PubMed ID: 37335161
[TBL] [Abstract][Full Text] [Related]
11. Curcumin and endometriosis: Review on potential roles and molecular mechanisms.
Arablou T; Kolahdouz-Mohammadi R
Biomed Pharmacother; 2018 Jan; 97():91-97. PubMed ID: 29080464
[TBL] [Abstract][Full Text] [Related]
12. Curcumin: therapeutical potential in ophthalmology.
Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial ascorbic acid transport is mediated by a low-affinity form of the sodium-coupled ascorbic acid transporter-2.
Muñoz-Montesino C; Roa FJ; Peña E; González M; Sotomayor K; Inostroza E; Muñoz CA; González I; Maldonado M; Soliz C; Reyes AM; Vera JC; Rivas CI
Free Radic Biol Med; 2014 May; 70():241-54. PubMed ID: 24594434
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
15. Curcumin prevents human aortic smooth muscle cells migration by inhibiting of MMP-9 expression.
Yu YM; Lin HC
Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):125-32. PubMed ID: 19447587
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential.
Fu YS; Chen TH; Weng L; Huang L; Lai D; Weng CF
Biomed Pharmacother; 2021 Sep; 141():111888. PubMed ID: 34237598
[TBL] [Abstract][Full Text] [Related]
17.
Feng L; Lu WH; Li QY; Zhang HY; Xu LR; Zang WQ; Guo WT; Li YF; Zheng WJ; Geng YX; Li Q; Liu YH
Am J Chin Med; 2023; 51(5):1189-1209. PubMed ID: 37314412
[TBL] [Abstract][Full Text] [Related]
18. Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management.
Moon DO
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474160
[TBL] [Abstract][Full Text] [Related]
19. [Turmeric - not only spice].
Zdrojewicz Z; Szyca M; Popowicz E; Michalik T; Śmieszniak B
Pol Merkur Lekarski; 2017 Jun; 42(252):227-230. PubMed ID: 28662006
[TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human colon adenocarcinoma cells.
Dasiram JD; Ganesan R; Kannan J; Kotteeswaran V; Sivalingam N
Biomed Pharmacother; 2017 Feb; 86():373-380. PubMed ID: 28011386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]